第六章、 結論與建議
第三節、 研究限制
由於本研究只是一橫斷性的研究(Cross-sectional research)，因此 對於各項因子，無法論斷其中因果關係。骨質密度低下與心血管疾
research ，進一步去釐清。
第七章、參考文獻
Adami S, Braga V, Zamboni M, Davide Gattti D, Rossini M, Bakri J, et al.
Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 2004; 74: 136-142
Binkley NB, Kendler DL, Leib ES, Lewiecki EM, Petak SM. Official positions of the international society for clinical densitometry and executive summary of the 2005 position development conference. J Clin Densitometry 2006；9: 4-14.
Cheng S, Fan B, Wang L, Fuerst T, Lian M, Njeh C, et al. Factors affecting broadband ultrasound attenuation results of the calcaneus using a gel-coupled quantitative ultrasound scanning system. Oseoporosis international 1999; 10: 495-504
Chiu HC, Mau LW, Liu HW. Prevalence of cardiovascular risk factors of elderly persons in Taiwan. Kaohsiung J Med Sci. 2002; 18: 53-61.
Chiu JF, Lan SJ, Yang CY, Wang PW, Yao WJ, Su LH, et al. Long term vegeterian diet and bone mineral in postmenopausal Taiwanese women.
Calcific Tissue International 1997; 60(3): 245-9
Claus CG. Quantitative ultrasound techniques for the assessment of osteoporosis:
expert agreement on current status. Journal of Bone & Mineral Research 1997; 12(8): 1280-1288.
D'agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, et al. Primary and subsequent coronary risk appraisal : new results from the Frammingham study. Am Heart J 2000; 139: 272-281.
Darmawan J, Valkenburn HA, Wigley RD. The epidermiology of gout and hyperuricemia in rural population of Java. The Journal of Rheumatology 1992; 19(10): 1595-1599.
Dennison E, Cooper C. Horm Res 2000; 54(suppl 1): 58-63.
Committee.The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure. Arch Inter Med 1993;153:154-82 .
Felson DT, Keel DP, Anderson JJ, Kannel W. Alcoho consumpstion and hip fractures: The Framingham study. Am J Epidemio 1988; 128: 1102-10 Frye MA, Joseph Melton III L, Bryant SC, Fitzpatrick LA, Wahner HW,
Schwartz RS, et al. Osteoporosis and calcification of the aorta. Bone Miner 1992; 19: 185-194.
Grampp S, Henk CB, Fuerst TP, Lu Y, Bader TR, Kainberger F, et al.
Diagnostic agreement of quantitative sonography of the calcaneous with dual X-ray absorptiometry of the spine and femur. AJR 1999; 173:
329-334.
Johansson C, Black D, Johnell O, Oden A, Mellstorm D. Bone mineral density is a predictor of survival. . Calcific Tissue International 1998; 63:
190-196.
Jorgensen L, Joakimsen O, Rosvold Berntsen GK, Heuch I, Jacobsen BK.
Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. American Journal of Epidemiology 2004; 160(6):
549-556.
Kannel WB. Diabetes and cardiovascular disease the Frammingham study.
JAMA 1979; 241: 2035-2038.
Lai SW, Tan CK. Association between serum uric acid and cardiovascular risk factors of elderly persons in Taiwan. Kaohsiung J Med Sci 1999; 15:
686-690.
Law MR, Hachshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997;
315:841-8
Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999; 353.
infarction in US adults. Osteoporos Int 2006; 16: 2053-2062.
Marcelo MP, and Vera L Szejnfeld. Low femoral bone mineral density and quantitative ultrasound are risk factors for new osteoporotic fracture and total and cardiovascular mortality: a 5 year population based study of Brasilian elderly women. J of Gerontology 2006; 61(A): 196-203.
Marin, F, Gonzalez-Macias J, Diez-Perez, A, Palma S, Delgado-Rodriguez, M.
Relationship between bone quantitative ultrasound and fractures: a meta-analysis. Journal of Bone & Mineral Research 2006; 21(7):
1126-1135.
Moris M, Peretz A, Tjeka R, Negaban N, Wouters M, Bergmann P.
Quantitative ultrasound bone measurements: normal values and comparison with bone mineral density by dual x-ray absorptiometry.
Calcified Tissue Int 1995; 57: 6-10.
Mussolino ME, Gillium RF. Bone mineral density and mortality in women and men. Ann Epidemiol 2003; 13: 692-697.
Nawroth P, Pirzer R, Fohr, B, Schilling T, Ziegler R, Bierhaus A, et al.
[Osteoporosis and cardiovascular disease--two sides of the same coin?].
Medizinische Klinik, 2003; 98(8): 437-446.
NIH Consensus development conference: prophylaxis and treatment of osteoporosis . Am J Med 1991; 90: 107-110.
NIH Consensus development Panel on Osteoprosis Prevention, Diagnosis, and Therapy. JAMA 2001; 285: 338-344.
Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 2004; 15, 389-395.
Riggs BL, Melton LJ 3rd . Involutional osteoporosis. New England J of Medicine 1986; 314(26): 1676-86
Samelson EJ, Cupples LA, Broe KE. Vascular calcification in middle age and long-term risk of hip fracture: the Framingham Study. J Bone Miner Res
Schott AM, Hans D, Duboeuf F, Dargent-Molina P, Hajri T, Breart G, et al.
Quantitative ultrasound parameters as well as bone mineral density are better predictors of trochanteric than cervical hip fractures in elderly women. Results from the EPIDOS study. Bone 2005; 37(6): 858-863.
Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 2004; 89:
4246-4253.
The Seventh Report of the Joint National Committee on Prevention, Detection, Elevation, and Treatment of High Blood Pressure. JAMA 2003;
289-295.
Shaw C, Abrams K, Marteau TM. Phychological impact of predicting individuals' risks of illness: a systematic review. Soc sci med 1999;
49(12): 1571-98
Soroko S, H. T., Edelstein S, Barrett-Connor E. Lifetime mild consumption and bone mineral density in older women. Am J Pulblic Health 1994; 84:
1319-22
Summary of the second report of the national cholesterol education program(NCPP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(adult treatment panel II). Paper presented at the National Cholesterol Education Program Committee. 1993.
Third report of the National Cholesterol Education Program(NCEP) Expert Panel on detection,evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III). Circulation 2002;106: 3143-3152.
Trivedi DP, & Khaw KT. Bone mineral density at the hip predicts mortality in elderly men. Osteoporosis International 2001; 12(4): 259-265.
Tsai KS. Osteoporotic fracture rate, bone mineral density, and bone metabolism in Taiwan. Journal of the Formosan Medical Association 1997; 96(10):
802-805.
Tsai KS, Cheng WC, Chen CK, Sanchez TV, Su CT, Chieng PU, et al. Effect
Bone 1997; 21(6): 547-551.
Tsai KS, Cheng WC, Sanchez TV, Chen CK, Chieng PU, Yang RS. Bone densitometry of proximal femur in Chinese subjects: gender differences in bone mass and bone areas. Bone 1997; 20(4): 365-369.
Tsai KS, Chieng PU, Huang KM, Su CT, Lee TK. Predictive value of total body bone mineral density for vertebral fractures in elderly women.
Geriatric Study Group. Journal of the Formosan Medical Association 1992; 91(9): 873-878.
Tsai KS, Ebeling PR, Riggs BL. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women. Journal of Clinical Endocrinology & Metabolism 1989; 69(5): 1024-1027.
Tsai KS, Heath H, 3rd, Kumar R, Riggs BL. Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis.
Journal of Clinical Investigation 1984; 73(6): 1668-1672.
Tsai KS, Hsu SH, Cheng W C, Chen CK, Chieng PU, Pan WH. Bone mineral density and bone markers in relation to vitamin D receptor gene polymorphisms in Chinese men and women. Bone 1996; 19(5):
513-518.
Tsai KS, Hsu SH, Yang RS, Cheng WC, Chieng PU. The effectiveness of cyclic and continuous oral clodronate therapy on bone density and markers in osteopenic postmenopausal women. Calcified Tissue International 1999; 64(5): 384-388.
Tsai KS, Tai TY. Epidemiology of osteoporosis in Taiwan. Osteoporosis International 1997; 7 Suppl 3: S96-98.
Tsai KS, Wahner HW, Offord KP, Melton LJ 3rd, Kumar R, Riggs B L. Effect of aging on vitamin D stores and bone density in women. Calcified Tissue International 1987; 40(5): 241-243.
Uyama O, Yashimoto Y, Yamamoto Y, Kawai A. Bone change and carotid atherosclerosis in postmenoausal women. Stroke 1997; 28: 1730-1732.
Laett CEDH. Bone mineral density and mortality in elederly men and women: the Rotterdam study. Bone 2002; 30: 643-648.
Von der Reche PHM, Hassanger C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 1999;106:
273-278.
World Health Organization. WHO Expert Committee in Diabetes Mellitus.
Second report. Technical report series 646. WHO Geneva, 1985.
Wuster C, de Terlizzi F, Becker S, Cadossi M, Cadossi R, Muller R.
Usefulness of quantitative ultrasound in evaluating structural and mechanical properties of bone: comparison of ultrasound, dual-energy X-ray absorptiometry, micro-computed tomography, and mechanical testing of human phalanges in vitro. Technology & Health Care 2005 13(6): 497-510.
Yang NP, Chou P. Epidemiology of osteoporosis in Taiwan. National Yang-Ming Univeristy, Taipei 2005
Yang NP, Deng CY, Chou YJ, Chen PQ, Lin CH, Chou P, et al. Estimated prevalence of osteoporosis from a Nationwide Health Insurance database in Taiwan. Health Policy 2006; 75(3): 329-337.
Yang NP, Lin T, Wang CS, Chou P. Community-based survey of low quantitative ultrasound values of calcaneus in Taiwan. Journal of Clinical Densitometry 2003; 6(2): 131-141.
Yang NP, Lin T, Wang CS, Chou P. Correlation of osteoporosis screening by quantitative ultrasound of calcaneus and Osteoporosis Self-Assessment Tool for Asians in Taiwanese. Journal of the Formosan Medical Association 2004; 103(2): 130-136.
Yetkin E, Yagmur C, Yagmur J,Tekin GO, Ketitti E, Uckan A et al. Evaluation of cardiovascular risk factors and bone mineral density in patients undergoing coronary angiography and relation of findings to mitral annular calcium. Am J Cardiol 2007; 99(2): 159-162. Epub 2006 Nov
周碧瑟、郭宏偉： 石牌地區居民骨質疏鬆症危險因子之探討。國立陽明大 學碩士論文 1998。
劉俐婷： 骨質疏鬆症之藥物治療新趨勢。 臨床醫學 2002; 49: 1-8。